SSII
SS Innovations International, Inc. NASDAQ Listed Oct 17, 2018$2.95
+0.00%
vs $2.95
Mkt Cap $590.4M
52w Low $2.89
0.8% of range
52w High $10.00
50d MA $3.56
200d MA $4.28
P/E (TTM)
—
EV/EBITDA
—
P/B
14.7x
Debt/Equity
0.1x
ROE
-31.7%
P/FCF
-26.4x
RSI (14)
23.30
ATR (14)
$0.18
Beta
1.91
50d MA
$3.56
200d MA
$4.28
Avg Volume
57.4K
SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.
1600 SE 15th Street · Fort Lauderdale, FL 33316 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | BMO | -0.01 | -0.01 | +0.0% | 3.69 | +0.3% | +3.8% | +1.6% | -3.3% | -1.3% | -3.0% | — |
| May 13, 2026 | BMO | -0.02 | -0.02 | +0.0% | 3.99 | +0.5% | +0.0% | -3.3% | +3.6% | +0.0% | -1.5% | — |
| Mar 10, 2026 | BMO | — | -0.01 | — | 4.42 | +14.3% | +9.7% | +2.3% | -10.1% | +6.7% | -0.2% | — |
| Oct 28, 2025 | BMO | — | -0.02 | — | 8.52 | +1.3% | +1.5% | -6.0% | +0.2% | -3.6% | -4.2% | — |
| Aug 7, 2025 | BMO | — | -0.00 | — | 6.68 | +0.6% | +1.3% | -7.7% | +3.0% | +0.9% | +3.8% | — |
| May 14, 2025 | BMO | — | -0.03 | — | 10.05 | +1.8% | -1.0% | -1.1% | -1.0% | -7.9% | -0.7% | — |
| Mar 27, 2025 | BMO | — | -0.04 | — | 9.40 | +0.0% | +0.0% | +6.4% | -2.5% | +0.0% | +2.6% | — |
| Nov 15, 2024 | BMO | — | -0.03 | — | 3.00 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +23.3% | — |
| Sep 6, 2024 | BMO | — | -0.02 | — | 0.32 | +1146.9% | +1146.9% | -0.5% | +0.0% | +0.0% | +0.0% | — |
| May 15, 2024 | BMO | — | -0.02 | — | 0.35 | -14.3% | +0.0% | +0.0% | +19.7% | +1.2% | -2.1% | — |
| Mar 22, 2024 | BMO | — | -0.09 | — | 0.60 | -8.3% | -8.3% | +9.1% | +0.0% | +0.0% | +0.2% | — |
| Nov 13, 2023 | BMO | — | -0.01 | — | 0.60 | -1.7% | -1.7% | +16.1% | +2.2% | +0.0% | +0.7% | — |
| Aug 7, 2023 | BMO | — | -0.05 | — | 1.56 | +0.0% | -1.9% | +2.0% | +0.6% | +0.6% | -0.6% | — |
| Jun 30, 2023 | AMC | — | -0.01 | — | 1.55 | +0.0% | +0.0% | +0.0% | +0.0% | -2.6% | -0.7% | — |
No analyst ratings available.
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Sudhir SrivastavaDir/Off | Chairman and CEO | Sell | 33,333 | $3.00 | $100K | 108,520,928 | +2.48% | -0.91% |
8-K · 8.01
!! High
SS Innovations International, Inc. -- 8-K 8.01: Material Event / Announcement
Sep 10
8-K · 5.02
!!! Very High
SS Innovations International, Inc. -- 8-K 5.02: Executive Change
Aug 26
8-K · 2.02
!! High
SS Innovations International, Inc. -- 8-K 2.02: Earnings Results
Aug 13
8-K · 8.01
!! High
SS Innovations International, Inc. -- 8-K 8.01: Material Event / Announcement
Jul 17
8-K
SS Innovations International, Inc. -- 8-K Filing
Jul 14
8-K · 8.01
!! High
SS Innovations International, Inc. -- 8-K 8.01: Material Event / Announcement
Jul 7
8-K · 8.01
!! High
SS Innovations International, Inc. -- 8-K 8.01: Material Event / Announcement
Jun 30
8-K · 7.01
! Medium
SS Innovations International, Inc. -- 8-K 7.01: Regulation FD Disclosure
SS Innovations International updated its investor presentation in June 2026, signaling potential messaging changes to shareholders and the market regarding company strategy and performance.
Jun 15
8-K · 8.01
!! High
SS Innovations International, Inc. -- 8-K 8.01: Material Event / Announcement
Jun 4
8-K · 5.02
!!! Very High
SS Innovations International, Inc. -- 8-K 5.02: Executive Change
May 26
8-K · 2.02
!! High
SS Innovations International, Inc. -- 8-K 2.02: Earnings Results
May 13
8-K · 8.01
!! High
SS Innovations International, Inc. -- 8-K 8.01: Material Event / Announcement
SS Innovations surpassed 10,500 cumulative surgeries using its Mantra surgical robotic system, demonstrating growing clinical adoption and market validation for the company's core product.
May 5
8-K · 7.01
! Medium
SS Innovations International Inc. -- 8-K 7.01: Regulation FD Disclosure
SS Innovations International unveiled cutting-edge surgical robotic technologies at its hosted 2026 Global Multi-Specialty Robotic Surgery Conference in New Delhi, signaling progress in advanced medical device development.
Apr 23
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
SS Innovations is hosting a major international robotic surgery conference, demonstrating market leadership and positioning to showcase technology innovations that could drive future adoption and revenue growth globally.
Apr 7
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
SS Innovations gained regulatory approval for its Mantra surgical robot in four emerging markets, expanding international commercial opportunities and diversifying revenue streams beyond developed economies.
Mar 30
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
SS Innovations' regulatory approvals for telesurgery in Indonesia and Philippines, combined with surpassing 150 cumulative procedures, validates market demand and expands addressable market in high-growth emerging economies, potentially driving significant revenue growth.
Mar 18
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
SSII's forward-looking statement disclaimers indicate management expects significant business changes ahead, but investors should recognize actual results may substantially differ due to undisclosed risks and uncertainties.
Mar 10
8-K
SS Innovations International Inc. -- 8-K Filing
SS Innovations International Inc.'s directors and executives purchased shares at the Nasdaq-determined minimum price, signaling insider confidence while the company prepares market expansion into the United States and European Union.
Mar 9
Valuation
Market Cap
$590.4M
Enterprise Value
$585.3M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
2.12x
P/B
14.67x
P/S
11.27x
P/FCF
-26.40x
EV/EBITDA
—
Shares Out
198.7M
Financials (TTM)
Revenue
$52.4M
Net Income
-$12.4M
EBITDA
-$6.2M
Free Cash Flow
-$22.2M
Op Cash Flow
-$18.5M
EPS Basic
$-0.06
EPS Diluted
$-0.07
EPS Forward
—
Gross Margin
47.0%
Op Margin
-16.2%
Net Margin
-23.7%
Balance Sheet
Total Assets
$74.2M
Total Liab.
$36.0M
Total Equity
$38.2M
Cash
$3.2M
LT Debt
$2.3M
Book Value/Sh
$0.20
Debt/Equity
0.08x
Current Ratio
1.86
Quick Ratio
1.21
Returns & Growth
ROE
-31.7%
ROA
-16.3%
ROIC
-16.8%
Rev Growth YoY
+105.4%
EPS Growth YoY
+42.0%
Price Returns
2W
-10.9%
1M
-17.4%
3M
-11.7%
6M
-40.2%
12M
-46.9%
Technicals
52W High
$10.00
52W Low
$2.89
50d MA
$3.56
200d MA
$4.28
RSI (14)
23.30
ATR (14)
$0.18
Beta
1.91
Avg Volume
57K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 27, 2026 2:56am
· Source: financialmodelingprep.com